Engineered extracellular vesicles efficiently deliver CRISPR-Cas9 ribonucleoprotein (RNP) to inhibit herpes simplex virus1 infection in vitro and in vivo
- Resource Type
- Article
- Source
- In
Acta Pharmaceutica Sinica B March 2024 14(3):1362-1379 - Subject
- Language
- ISSN
- 2211-3835